Francis DeGuzman
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 6
- Hematology top 1%
- Platelet Disorders and Treatments 10
- Blood Coagulation and Thrombosis Mechanisms 4
-
- Atrial Fibrillation Management and Outcomes 7
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Immunology and Allergy top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
-
- Heparin-Induced Thrombocytopenia and Thrombosis 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- David R. PhillipsPamela B. ConleyUma SinhaStanley J. HollenbachMayuko InagakiGenmin LuAthiwat HutchaleelahaKeith Abe
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)Circulation (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Francis DeGuzman
27 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Internal Medicine 561
- Hematology 748
- Cardiology and Cardiovascular Medicine 904
- Immunology and Allergy 206
- Genetics 170
Countries citing papers authored by Francis DeGuzman
This map shows the geographic impact of Francis DeGuzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis DeGuzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis DeGuzman more than expected).
Fields of papers citing papers by Francis DeGuzman
This network shows the impact of papers produced by Francis DeGuzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis DeGuzman. The network helps show where Francis DeGuzman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francis DeGuzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2018 | 30 | |
| 4 | 2018 | 2 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 4 | |
| 7 | 2014 | 73 | |
| 8 | A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xabreakdown → | 2013 | 533 |
| 9 | 2012 | 40 | |
| 10 | 2012 | 4 | |
| 11 | 2011 | 21 | |
| 12 | 2011 | 91 | |
| 13 | Abstract 12420: Reversal of Low Molecular Weight Heparin and Fondaparinux by a Recombinant Antidote (r-Antidote, PRT064445) | 2010 | 8 |
| 14 | 2010 | 100 | |
| 15 | 2005 | 82 | |
| 16 | 2003 | 269 | |
| 17 | 2003 | 13 | |
| 18 | 2000 | 11 | |
| 19 | 1999 | 251 | |
| 20 | 1999 | 74 |
About Francis DeGuzman
Francis DeGuzman is a scholar working on Internal Medicine, Hematology and Genetics, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (10 papers), Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Internal Medicine (561 citations), Hematology (748 citations) and Cardiology and Cardiovascular Medicine (904 citations). Francis DeGuzman has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include David R. Phillips, Pamela B. Conley, Uma Sinha, Stanley J. Hollenbach, Mayuko Inagaki, Genmin Lu, Athiwat Hutchaleelaha, Keith Abe, Peng Luan and Mark J. Karbarz. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.